, Volume 236, Issue 7, pp 2285–2286 | Cite as

Omega-3 consumption and sudden unexpected death in schizophrenia: a “fish” a day keeps heart disease away

  • Fulvio A. ScorzaEmail author
  • Carla A. Scorza
  • Ana C. Fiorini
  • Jair de Jesus Mari
  • Leandro Freitas
  • Josef Finsterer
Letter to the Editor

Always on the lookout for articles from Psychopharmacology, one in particular has attracted a lot of attention because the results are really fascinating. Xu and colleagues addressed a priority issue in clinical research demonstrating that omega-3 fatty acids (O3FAs) have beneficial effects on triglyceride metabolism in patients with both schizophrenia and metabolic syndrome (MetS) that parallel decreased inflammation levels (Xu et al. 2019). Considering the conflicting published data concerning the role of O3FAs in treating MetS (especially elevated triglyceride levels) in people with schizophrenia, we applaud the authors for pursuing this topic. Moreover, this proposal cited above also deserves reflections with respect to sudden unexpected death (SUD) in schizophrenia.

Schizophrenia is a lifelong, chronic, and severely debilitating mental illness that is often diagnosed in late adolescence or early adulthood (Pennington and McCrone 2017). Unfortunately, life expectancy of...


Author contribution

All wrote and reviewed the final version of the article.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Xu F, Fan W, Wang W, Tang W, Yang F, Zhang Y, Cai J, Song L, Zhang C (2019) Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial. Psychopharmacology.
  2. Pennington M, McCrone P (2017) The cost of relapse in schizophrenia. Pharmacoeconomics 35:921–936CrossRefGoogle Scholar
  3. Li KJ, Greenstein AP, Delisi LE (2018) Sudden death in schizophrenia. Curr Opin Psychiatry 31:169–175CrossRefGoogle Scholar
  4. Scorza FA, Cysneiros RM, Terra VC, Scorza CA, Cavalheiro EA, Ribeiro MO, Gattaz WF (2009 Oct) Omega-3 consumption and sudden cardiac death in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 81(4):241–245CrossRefGoogle Scholar
  5. Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J, on behalf of the CLAMORS Study Collaborative Group (2007) Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr Res 90:162–173CrossRefGoogle Scholar
  6. Scorza FA, Cysneiros RM, Cavalheiro EA, Arida RM, de Albuquerque M (2007) Omega-3 fatty acids and sudden cardiac death in schizophrenia: if not a friend, at least a great colleague. Schizophr Res 94:375–376CrossRefGoogle Scholar
  7. Auquier P, Lancon C, Rouillon F, Lader M, Holmes C (2006) Mortality in schizophrenia. Pharmacoepidemiol Drug Saf 15:873–879CrossRefGoogle Scholar
  8. Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, Palmer S, Browne C, Wallace C (1998) Sudden death in psychiatric patients. Br J Psychiatry 172:331–336CrossRefGoogle Scholar
  9. Scorza FA, Mari JJ, Bressan RA (2006) Sudden cardiac death in schizophrenia: should the psychiatrist pay more attention? Rev Bras Psiquiatr 28:339CrossRefGoogle Scholar
  10. Glassman AH (2005) Schizophrenia, antipsychotic drugs, and cardiovascular disease. J Clin Psychiatry 66:5–10CrossRefGoogle Scholar
  11. Straus SM, Bleumink GS, Dieleman JP, van der Lei J, Jong GW, Kingma JH, Sturkenboom MC, Stricker BH (2004) Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 164:1293–1297CrossRefGoogle Scholar
  12. Zarate CA, Patel J (2001) Sudden cardiac death and antipsychotic drugs: do we know enough? Arch Gen Psychiatry 58:1168–1171CrossRefGoogle Scholar
  13. Pansani AP, Colugnati DB, Scorza CA, de Almeida AC, Cavalheiro EA, Scorza FA (2016) Furthering our understanding of SUDEP: the role of animal models. Expert Rev Neurother 16(5):561–572CrossRefGoogle Scholar
  14. Nejm MB, Haidar AA, Hirata AE, Arida RM, Naffah-Mazacoratti Mda G, Cavalheiro EA, Cysneiros RM, Scorza FA (2012) Interleukin-6 bares a dark side in sudden unexpected death in epilepsy. Epilepsy Behav 24:285–286CrossRefGoogle Scholar
  15. Nejm MB, Haidar AA, Hirata AE, Oyama LM, de Almeida AG, Cysneiros RM, Cavalheiro EA, Scorza CA, Scorza FA (2017) Fish oil supplementation reduces heart levels of interleukin-6 in rats with chronic inflammation due to epilepsy. Front Neurol 8:263CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Fulvio A. Scorza
    • 1
    Email author
  • Carla A. Scorza
    • 1
  • Ana C. Fiorini
    • 2
    • 3
  • Jair de Jesus Mari
    • 4
  • Leandro Freitas
    • 1
  • Josef Finsterer
    • 5
  1. 1.Disciplina de NeurociênciaUniversidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM)São PauloBrazil
  2. 2.Programa de Estudos Pós-Graduado em FonoaudiologiaPontifícia Universidade Católica de São Paulo (PUC-SP)São PauloBrazil
  3. 3.Departamento de FonoaudiologiaEscola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP)São PauloBrazil
  4. 4.Departamento de PsiquiatriaUniversidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM)São PauloBrazil
  5. 5.Krankenanstalt Rudolfstiftung, Messerli InstituteVeterinary University of ViennaViennaAustria

Personalised recommendations